IMU Biosciences, a Kfund portfolio company, secures £11.5 million in Series A funding to revolutionise immune powered precision medicine

by K Fund

MU Biosciences, a techbio company revolutionising immune powered precision medicine, has announced the close of a £11.5 million Series A financing round. The round was led by European tech VC Molten ...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Alantra Private Equity strengthens AIVOR...

by Alantra

AIVORIQ has grown significantly since Alantra PE launched the project....

Photos Stream